Teva Sub Says It Should Also Be Cut From FTC Androgel Suit
Teva subsidiary Actavis Holdco Inc. told a Georgia federal court Tuesday the government's dismissal of Par Pharmaceuticals Inc. supports its own bid to exit a lawsuit by the U.S. Federal Trade...To view the full article, register now.
Already a subscriber? Click here to view full article